Jerzy Daniluk

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

Vincent Meininger, Angela Genge, Leonard H van den Berg et al. · The Lancet Neurology · 2017 · 85 citations · Full text

Life Sciences, Neurology, Neuroscience +10

Safety of retigabine in adults with partial-onset seizures after long-term exposure: focus on unexpected ophthalmological and dermatological events

Neil Brickel, K. Hewett, Kirsty Rayner et al. · Epilepsy & Behavior · 2019 · 44 citations · Full text

Medicine, Dermatology, Pharmacology +16

Survey of Physicians’ Understanding of Specific Risks Associated with Retigabine

Jerzy Daniluk, James A. Cooper, Monika Stender et al. · Drugs - Real World Outcomes · 2016 · 15 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures

Holger Lerche, Jerzy Daniluk, Narinder Lotay et al. · Seizure · 2015 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Current status of epilepsy health care for adult patients from Central and Eastern European Union Countries—A survey of members of the Central Europe Epilepsy Experts Working Group

Joanna Jędrzejczak, Petr Marusič, Sulev Haldre et al. · Seizure · 2013 · 12 citations

Medicine, Health Policy, Neurology +17